You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CALCIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Calcium patents expire, and when can generic versions of Calcium launch?

Calcium is a drug marketed by Amneal Pharms, Chartwell Rx, Heritage Pharms Inc, Hikma, Invagen Pharms, Lotus Pharm Co Ltd, Lupin Ltd, Nostrum Labs Inc, Square Pharms, Suven Pharms, Chartwell Molecular, Padagis Us, Amneal, Am Regent, Intl Medication Sys, Medefil Inc, Hospira, Bausch, Abbott, Abraxis Pharm, Lilly, B Braun Medical Inc, Fresenius Kabi Usa, Nivagen Pharms Inc, Somerset, and Hq Spclt Pharma. and is included in thirty-one NDAs. There are two patents protecting this drug.

The generic ingredient in CALCIUM is calcium gluconate. There are two hundred and eighty-two drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the calcium gluconate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Calcium

A generic version of CALCIUM was approved as calcium gluconate by FRESENIUS KABI USA on June 15th, 2017.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CALCIUM?
  • What are the global sales for CALCIUM?
  • What is Average Wholesale Price for CALCIUM?
Summary for CALCIUM
Drug patent expirations by year for CALCIUM
Drug Prices for CALCIUM

See drug prices for CALCIUM

Drug Sales Revenue Trends for CALCIUM

See drug sales revenues for CALCIUM

US Patents and Regulatory Information for CALCIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 208418-005 Jun 17, 2021 AP RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Fresenius Kabi Usa CALCIUM GLUCONATE calcium gluconate SOLUTION;INTRAVENOUS 208418-003 Jun 15, 2017 AP RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Hq Spclt Pharma CALCIUM GLUCONATE IN SODIUM CHLORIDE calcium gluconate SOLUTION;INTRAVENOUS 210906-003 Jun 4, 2021 RX Yes Yes 10,342,813 ⤷  Subscribe Y ⤷  Subscribe
Amneal CALCIUM GLUCONATE calcium gluconate SOLUTION;INTRAVENOUS 216611-003 May 10, 2024 AP RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Nivagen Pharms Inc CALCIUM GLUCONATE calcium gluconate SOLUTION;INTRAVENOUS 213071-001 Oct 14, 2022 AP RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
B Braun Medical Inc CALCIUM GLUCONATE calcium gluconate SOLUTION;INTRAVENOUS 216541-001 Aug 21, 2023 AP RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

CALCIUM Market Analysis and Financial Projection Experimental

The Calcium Supplements Market: A Comprehensive Overview of Market Dynamics and Financial Trajectory

Market Size and Growth Projections

The calcium supplements market is poised for significant growth over the coming years. As of 2024, the global market size is estimated to be around USD 5,759.5 million, and it is projected to reach USD 9,223 million by 2034, growing at a Compound Annual Growth Rate (CAGR) of approximately 4.8% during this period[1].

Drivers of Market Growth

Increasing Health Awareness

One of the primary drivers of the calcium supplements market is the rising awareness about the importance of calcium for bone health. Consumers are becoming more informed about the adverse effects of calcium deficiency, leading to an increased demand for calcium supplements. This trend is particularly evident in countries like the United States, Germany, and Italy, where health awareness is high[1].

Aging Population

The expanding geriatric population, especially in developed nations such as China, is a significant factor contributing to the market's growth. Senior citizens often suffer from calcium deficits, which can lead to bone-related disorders like osteoporosis. As a result, health experts recommend calcium supplements to this demographic, driving up sales[1].

Lifestyle and Dietary Factors

The increasing prevalence of lifestyle disorders due to sedentary lifestyles and nutritional deficiencies also fuels the demand for calcium supplements. Women, in particular, are more prone to calcium deficiency, making them a key target market for these products. Additionally, the growing vegan population, which does not consume milk, is turning to calcium supplements to meet their daily calcium requirements[1].

Technological Advancements and Product Innovation

Suppliers in the market are investing heavily in research and development, leading to innovative formulations and improved bioavailability and efficacy of calcium supplements. The introduction of various forms such as tablets, powders, and syrups, including plant-based options for vegans, is catering to diverse consumer preferences and driving market growth[3].

Regional Market Dynamics

Asia Pacific

The Asia Pacific region is a dominant force in the global calcium supplements market, accounting for more than 40% of the market share. Countries like China, India, Japan, and South Korea have a large and aging population, which is increasingly susceptible to bone health issues like osteoporosis. Government initiatives promoting calcium supplementation and rising disposable incomes are further boosting the market in this region[3][5].

North America

North America is the fastest-growing region in the calcium supplements market over the forecast period. The high prevalence of osteoporosis and a proactive approach towards health prevention measures are key factors driving this growth. Market leaders such as Nature Made and Caltrate are continuously innovating and introducing new products to meet the evolving needs of consumers[3].

Europe

European countries, particularly Italy, are experiencing a higher sales trajectory for calcium supplements due to increasing health awareness. The CAGR for Italy is projected to be around 5.7%, which is higher than the global average[1].

Economic Benefits and Cost-Effectiveness

Healthcare Savings

Calcium and vitamin D supplementation have been shown to be cost-effective, particularly in orthopaedic trauma patients. A study found that a 5% reduction in nonunion risk due to vitamin D and calcium supplementation could save $78,030 in treatment costs per year, outweighing the cost of supplementation by $65,866 annually[2].

Consumer Spending

The increasing awareness and demand for calcium supplements are leading to higher consumer spending on healthcare. As consumers become more proactive about their health, they are willing to invest in supplements that support bone health and overall well-being[3].

Market Segmentation

By Type

The market is segmented into child calcium supplements and adult calcium supplements. The adult segment is larger due to the higher prevalence of osteoporosis and other bone-related disorders in this age group[5].

By Form

Calcium supplements are available in various forms, including syrups, tablets, and powders. The diversity in product forms caters to different consumer preferences and needs, contributing to the market's growth[5].

Key Players and Competitive Landscape

Market leaders such as Himalaya Herbal Healthcare, Amway, Nature Made, and Caltrate are investing significantly in marketing campaigns and product innovation. These companies are focusing on creating awareness about the importance of calcium supplementation and introducing new products that meet the changing needs of consumers[3].

Technological Integration

The integration of technology in healthcare, including mobile applications for health and wellness, is also supporting the growth of the calcium supplements market. These technologies help in monitoring and managing health more effectively, further boosting the demand for calcium supplements[3].

Key Takeaways

  • The global calcium supplements market is projected to grow from USD 5,759.5 million in 2024 to USD 9,223 million by 2034 at a CAGR of 4.8%.
  • Increasing health awareness, an aging population, and lifestyle factors are key drivers of market growth.
  • The Asia Pacific region dominates the market, while North America is the fastest-growing region.
  • Calcium and vitamin D supplementation are cost-effective and can lead to significant healthcare savings.
  • Market segmentation includes child and adult supplements, as well as various forms like syrups, tablets, and powders.

FAQs

Q: What is the projected market size of the calcium supplements market by 2034?

A: The global calcium supplements market is projected to reach USD 9,223 million by 2034[1].

Q: What are the main drivers of the calcium supplements market?

A: The main drivers include increasing health awareness, an aging population, and lifestyle factors such as sedentary lifestyles and dietary preferences[1].

Q: Which region dominates the global calcium supplements market?

A: The Asia Pacific region dominates the global calcium supplements market, accounting for more than 40% of the market share[3][5].

Q: How cost-effective is calcium and vitamin D supplementation?

A: Calcium and vitamin D supplementation can save significant healthcare costs by reducing nonunion rates in orthopaedic trauma patients, resulting in a net savings of $65,866 per year[2].

Q: What forms are calcium supplements available in?

A: Calcium supplements are available in various forms, including syrups, tablets, and powders, catering to different consumer preferences[5].

Sources

  1. Future Market Insights, "Calcium Supplements Market Size, Share & Trends by 2034 | FMI"
  2. PubMed, "Economic Benefit of Calcium and Vitamin D Supplementation"
  3. GlobeNewswire, "Calcium Supplements Market Is Expected To Reach Around USD 0.91 Billion In 2032"
  4. DrugBank Online, "Calcium: Uses, Interactions, Mechanism of Action | DrugBank Online"
  5. SNS Insider, "Calcium Supplements Market Size, Share & Industry Growth"

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.